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Abstract
Background: Various members of the mint family have been used historically in Chinese and Native
American medicine. Many of these same family members, including Prunella vulgaris, have been reported to
have anti-viral activities. To further characterize the anti-lentiviral activities of P. vulgaris, water and ethanol
extractions were tested for their ability to inhibit equine infectious anemia virus (EIAV) replication.
Results: Aqueous extracts contained more anti-viral activity than did ethanol extracts, displaying potent
anti-lentiviral activity against virus in cell lines as well as in primary cell cultures with little to no cellular
cytotoxicity. Time-of-addition studies demonstrated that the extracts were effective when added during
the first four h of the viral life cycle, suggesting that the botanical constituents were targeting the virion
itself or early entry events. Further analysis revealed that the extracts did not destroy EIAV virion integrity,
but prevented viral particles from binding to the surface of permissive cells. Modest levels of anti-EIAV
activity were also detected when the cells were treated with the extracts prior to infection, indicating that
anti-EIAV botanical constituents could interact with both viral particles and permissive cells to interfere
with infectivity. Size fractionation of the extract demonstrated that eight of the nine fractions generated
from aqueous extracts displayed anti-viral activity. Separation of ethanol soluble and insoluble compounds
in the eight active fractions revealed that ethanol-soluble constituents were responsible for the anti-viral
activity in one fraction whereas ethanol-insoluble constituents were important for the anti-viral activity in
two of the other fractions. In three of the five fractions that lost activity upon sub-fractionation, anti-viral
activity was restored upon reconstitution of the fractions, indicating that synergistic anti-viral activity is
present in several of the fractions.
Conclusion: Our findings indicate that multiple Prunella constituents have profound anti-viral activity
against EIAV, providing additional evidence of the broad anti-viral abilities of these extracts. The ability of
the aqueous extracts to prevent entry of viral particles into permissive cells suggests that these extracts
may function as promising microbicides against lentiviruses.
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Background
P. vulgaris, commonly known as "self-heal", is a low-grow-
ing perennial herb with worldwide distribution. The herb
is a member of the mint family Lamiaceae. Salves, teas,
and extracts made from the plant have been used to treat
wounds, inflammation, and other minor body disorders
by both the Chinese and Native Americans [1,2].
Various bioactive constituents have been identified in
extracts of P. vulgaris. These include phenolic constituents,
complex carbohydrates and more hydrophobic metabo-
lites such as triterpenes. The abundant polysaccharides
present in P. vulgaris are readily extracted by water and
have a number of reported biological activities [3,4], and
several of the triterpenes have been identified with signif-
icant anti-inflammatory activity [5]. Large quantities of
anti-oxidants are known to be present in aqueous Prunella
extracts with the polyphenolic compound, rosmarinic
acid, being one of the most abundant of these constitu-
ents [6,7]. Rosmarinic acid has also been shown to have
anti-inflammatory activity as a result of specific inhibition
of T cell signaling and an impact on glucose metabolism
[8-10].
Prunella extracts have been reported to contain anti-viral
and anti-bacterial properties, although constituents
responsible for these activities are incompletely character-
ized to date [7,11,12]. Recent research has confirmed that
anionic polysaccharides in aqueous extracts of P. vulgaris
can decrease the replication of herpes simplex virus-1 and
-2 (HSV-1, HSV-2) by preventing viral binding to cells
[11,13-15]. P. vulgaris extracts have also been shown to
contain anti-HIV activity. Studies have identified inhibi-
tion of HIV infection at steps of virus binding [16], fusion
[17], reverse transcription [12], integration [18], and pro-
tease function [19]. Many of these studies identified
Prunella  antiviral activity through high through-put
screens for specific viral protein targets in in vitro assays.
While constituents in Prunella  may be effective against
these numerous anti-HIV targets in vitro, inhibition of the
specific targets responsible for anti-HIV activity of Prunella
in cells remains unclear. Identification of constituents of
P. vulgaris that confer the inhibition to HIV-1 is limited to
the water soluble, 10 kDa polysaccharide, Prunellin, that
interferes with HIV-1 virion binding to permissive cells
[16,20]. Rosmarinic acid extracted from other botanicals
has proved effective against HIV-1 integrase [21], but the
role of this polyphenol in the anti-retroviral activities of
Prunella extracts has not been explored. Additional mem-
bers of the Lamiaceae, such as peppermint and lemon
balm, are also known to have anti-viral activities, but spe-
cific constituents responsible for those activities remain
unidentified [13,22].
In this study we sought to examine the breadth of the anti-
lentiviral activity of water and ethanol extracts from sev-
eral P. vulgaris accessions by investigating their ability to
inhibit replication of equine infectious anemia virus
(EIAV). Water extracts of two of the accessions that had
the greatest anti-viral activity were determined to interfere
with virus binding and uptake. Our studies identified sev-
eral different constituents present in the aqueous extracts
that had significant activity against EIAV. Our findings
suggest that this extract may serve as an effective microbi-
cide against lentiviruses.
Methods
Growth and collection of P. vulgaris accessions
All Prunella vulgaris plant samples were provided by the
North Central Regional Plant Introduction Station
(NCRPIS, Ames, IA) of the Agricultural Research Service of
the U.S Department of Agriculture. All samples utilized in
experiments were produced from populations collected
from North Carolina or Missouri in October, 2004 on a
collection trip sponsored by the USDA/NCRPIS/ISU/NIH.
Both seed and voucher specimens were collected from all
original sites and specimens were keyed to species [31].
Seeds from accessions Ames 27664, 27665, 27666 and
27748 were germinated in Petri plates at 25°C, transferred
to flats in a greenhouse (20–25°C) before final field trans-
fer into individual control pollinated screened cages in
Ames, IA. Upper flowering portions of 14 month old
plants were harvested, dried for 1 week at 38 °C in a
forced-air dryer with constant humidity and ground (RTC-
R301ULTRAB) for analysis. All voucher specimens repre-
senting both original and regenerated populations are
stored in the Ada Hayden Herbarium, Iowa State Univer-
sity (Ames, IA: ISC). Seeds representing both original and
regenerated populations are stored at the USDA NCRPIS
under controlled conditions (-20°C, 4°C for regenerated
samples). Information about the specific provenance of
all accessions used for the experiments is available via the
Germplasm Resources Information Network database at
http://www.ars-grin.gov/npgs/acc/acc_queries.html.
Extraction and fractionation of P. vulgaris
All glassware was heated at 200°C for 2 h to destroy endo-
toxin.
Water extraction
One hundred mL of boiling, endotoxin-free water was
poured over 6 g of dried P. vulgaris. The plant material was
steeped, with stirring, for 1 h and filtered through a G6
glass fiber circle (Fisher Scientific) in a Buchner funnel.
The filtrate was centrifuged at 10,000 × g for 20 minutes
to remove any additional particulates. The extract was
lyophilized, weighed, and re-dissolved in DMSO.Virology Journal 2009, 6:8 http://www.virologyj.com/content/6/1/8
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Ethanol extraction
Six g of dried P. vulgaris was extracted with 500 mL of 95%
ethanol via Soxhlet for 6 h. The extract was filtered, dried
by rotary evaporation at < 40°C and then lyophilized.
Extracts were resuspended in DMSO.
Size-exclusion fractionation
Two g of dry Prunella water extract, dissolved in 10 mL
endotoxin-free water, was loaded onto a 2.5 × 75 cm
Sephacryl 100HR column. Endotoxin-free water was used
to elute the size-exclusion column. Two L of eluent was
collected in 10 mL fractions collected for 72 h. Absorb-
ance at 210 nm was measured for all fractions to monitor
separation efficiency and identify peaks. Nine peaks were
detected. Fractions composing these peaks were pooled
and concentrated by lyophylization. Fractions were resus-
pended in endotoxin-free water.
Endotoxin levels of extracts and fractions
All extracts and fractions were evaluated for endotoxin
using the Chromogenic Limulus Amebocyte Lysate Test
kit per manufacturer's instructions (Cambrex Bioscience
Inc.). This assay is able to detect concentrations of endo-
toxin of 0.007 EU/mL or greater. All extracts had <0.007
EU/mL at the highest concentrations used in these studies.
The fractions had slightly higher endotoxin levels; the
highest amount of endotoxin present in the fractions
when diluted for these studies was 0.023 EU/mL.
Separation of ethanol soluble and insoluble constituents in 
the size fractionated fractions
Sufficient 100% ethanol was added to each fraction to
yield a 95% ethanol solution. These fractions were placed
in a rotary shaker at room temperature for 1h. Fractions
were centrifuged at 10,000 × g for 20 min. The ethanol-
soluble supernatant was decanted, and the ethanol-insol-
uble pellet was redissolved in endotoxin-free water. Each
sub-fraction was lyophilized and weighed and resus-
pended in endotoxin-free water.
Cells and viral strains
Equine dermis cells (ED cells) (ATCC CCL57) were main-
tained in high glucose DMEM with 15% fetal calf serum
(FCS). Primary equine umbilical vein endothelial cells
(eUVEC) were also used in the EIAV studies and were
maintained in high glucose DMEM with 40% FCS. All
media were supplemented with penicillin and streptomy-
cin.
Stocks of EIAV were generated in ED cells. Viral stocks of
EIAVWSU5 [23], EIAVMA-1 [24], EIAVvMA-1c [25], EIAVSP19
[26], and EIAVTh1 [24] from ED cell supernatants were
harvested from cells that were >95% positive for EIAV
antigen as determined by EIAV antigen immunostaining.
Supernatants were centrifuged for 5 min at 13,500 × g to
remove cell debris, aliquoted, and frozen at -80°C until
needed. Viral titers were determined by infection of ED
cells using the single round of infection assay described
below.
Viral infection and time-of-addition studies
Inhibition of infectivity studies
All extracts were resuspended in DMSO, and fractions and
sub-fractions were resuspended in water. 250 infectious
particles of EIAV were combined with the concentrations
of extracts, fractions or sub-fractions as noted in the fig-
ures. The amount of DMSO was adjusted so that equiva-
lent concentrations of DMSO were present in all wells
within an experiment. No more than 1.5% DMSO was
used, as ED cell cytotoxicity was observed at higher DMSO
concentrations. In experiments where extracts were stud-
ied, the quantity of DMSO was carefully controlled. As the
total concentration of botanical constituents varied
slightly between the different accession extracts, the quan-
tity of constituents assayed was slightly different for each
accession. The constituent concentrations that were used
are noted in Table 1 and in the relevant figure legends. The
extract and virus mixture were added to 5 × 104 cells/well
of ED cells or eUVEC in a 48-well format resulting in a
multiplicity of infection (MOI) of ~0.005. The cells were
maintained for 40 h. Cells were fixed with 75% acetone/
25% water fixation and immunostaining of the cells for
EIAV antigens was performed as previously described
[27]. The EIAV antigen-positive cells within the infected
cell monolayer were counted and titers determined. IC50
and IC90 concentrations were determined using Table-
Curve software (Systat Academic).
Inhibition of entry studies
EIAVWSU5 was added to ED cells at an MOI of 0.005 in ED
media. DMSO or extracts of P. vulgaris Ames 27664 or
Ames 27748 extract was added to the well at 0, 1, 2, 3, 4,
6, and 8 h following infection at a final concentration of
0.2% DMSO (66 μg/mL of Ames 27664 or 62.4 μg/mL of
Ames 27748). Forty h following infection the cells were
fixed, immunostained for EIAV antigen and the EIAV pos-
itive cells enumerated.
Cell bound EIAV studies
EIAVWSU5 was bound to ED cells at 4°C for 1 h to permit
binding, but prevent virion internalization. The cells were
warmed to 37°C and DMSO or Prunella extract was added
to the well at 0, 1, 2, 3, 4, 6, and 8 h following temperature
shift at a final concentration of 0.2% DMSO (66 μg/mL of
Ames 27664 or 62.4 μg/mL of Ames 27748). Forty h fol-
lowing infection the cells were fixed, immunostained for
EIAV antigens and EIAV-positive cells enumerated.Virology Journal 2009, 6:8 http://www.virologyj.com/content/6/1/8
Page 4 of 13
(page number not for citation purposes)
Internalization studies
EIAVWSU5 was bound to ED cells at 4°C for 1 h to permit
binding, but prevent virion internalization. Unbound
virus was removed, new media replaced, and the cells
shifted to 37°C to promote internalization. At 0, 1, 2, 4,
and 6 h following temperature shift, the cells were washed
briefly in citrate acid buffer (pH 3.0) to inactivate any
non-internalized virions. The citrate buffer was removed
and cells were washed twice, and medium contain 0.2%
of DMSO, 66 μg/mL of Ames 27664 extract, or 62.4 μg/
mL of Ames 27748 extract was added to determine if the
extracts had any inhibitory effect on virions that had
already been internalized.
Virion stability studies
EIAV viral stock was incubated in DMEM with 10% fetal
calf or DMEM 10% fetal calf plus 132 μg/mL of Ames
27664 extract or 126 μg/mL of Ames 27748 extract. The
virus stock was maintained at 37°C and used to infect ED
cells at various time points following extract exposure.
The final concentration of Prunella when diluted on the
cells was 0.44 μg/mL of Ames 27664 extract or 0.42 μg/mL
of Ames 27748 extract. At 40 h following initiation of
infection, the cells were fixed and immunostained for the
production of EIAV proteins.
Viral binding assay
Virus was mixed with 132 μg/mL of Ames 27664 extract or
126 μg/mL of Ames 27748 extracts (final concentration of
0.4% DMSO) or fractions (100 ug/mL) and incubated
with ED cells (MOI of 2) at 4°C for 2 h to permit binding,
but prevent virion internalization. Unbound virions were
removed and cells were washed with phosphate buffered
saline (PBS) three times to ensure all unbound virions
were removed from the cells. Each well was lysed in 50 μL
of lysis buffer (50 mM Tris HCl (pH 8), 120 mM NaCl,
and 0.5% NP40, and 1 U/mL of protease inhibitor cock-
tail (Sigma). The lysates were analyzed by immunoblot-
ting for the presence of viral capsid to indicate virus
binding as described below. Blots were re-probed for cel-
lular β-tubulin to normalize for cellular input.
Inhibition of virion infectivity studies
105  infectious particles of EIAVwsu5  were incubated at
room temperature for 10 min with P. vulgaris Ames acces-
sion 27664 aqueous extract. Following the incubation,
dilutions of the incubated virus were added to ED cells in
a 48-well format and appropriate concentrations of
extract were maintained on the cells for the duration of
the experiment. Cells were fixed at 40 h following infec-
tion and immunostained as described above. Wells with
serial dilutions containing between 10 and 250 virus pos-
itive cells were enumerated and back-calculations were
made to obtain the numbers of infectious units of virus/
mL.
Immunoblotting
Cell lysates were run on NuPAGE Novex Bis-Tris Mini Gels
(Invitrogen) and transferred to nitrocellulose. EIAV capsid
was detected using the 2085 sera (1:10000) and second-
ary anti-horse antisera (1:10000) that was used for immu-
nostaining. Tubulin was detected by the E7 monoclonal
antibody (1:2000) (NIH Developmental Studies Hybrid-
oma Bank, University of Iowa) and sheep anti-mouse
HRP secondary (GE Healthcare) (1:50,000). All immuno-
blots were visualized using WestDura (Pierce).
Table 1: Concentrations of Prunella stocks
Botanical Concentration
(mg/mL)
Extracts:* 33.0
Ames 27664 – water 21.1
Ames 27665 – water 29.8
Ames 27666 – water 31.2
Ames 27748 – water 33.4
Ames 27664 – ethanol 34.6
Ames 27665 – ethanol 32.1
Ames 27666 – ethanol 33.7
Ames 27748 – ethanol
Fractions: 100
Fraction 1 100
Fraction 2 100
Fraction 3 100
Fraction 4 100
Fraction 5 100
Fraction 6 100
Fraction 7 100
Fraction 8 100
Fraction 9 100
Sub-fractions:
Ethanol soluble 1 89.1
Ethanol soluble 2 40.6
Ethanol soluble 3 53.0
Ethanol soluble 4 41.0
Ethanol soluble 5 29.1
Ethanol soluble 6 93.9
Ethanol soluble 7 63.5
Ethanol soluble 8 19.7
Ethanol soluble 9 70.5
Ethanol insoluble 1 10.9
Ethanol insoluble 2 59.4
Ethanol insoluble 3 46.9
Ethanol insoluble 4 59.0
Ethanol insoluble 5 70.9
Ethanol insoluble 6 6.2
Ethanol insoluble 7 36.5
Ethanol insoluble 8 80.3
Ethanol insoluble 9 29.6
* = all solvent used in the extraction procedure was removed from 
the extracts and extract material was resuspended in DMSO. All 
fractions and subfractions were resuspended in sterile water.Virology Journal 2009, 6:8 http://www.virologyj.com/content/6/1/8
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Sucrose-gradient centrifugation
Sucrose step gradients were prepared by layering 250 μL
aliquots of decreasing concentrations of sucrose (20%–
60%) into 3 mL ultra centrifugation tubes. The gradients
were allowed to equilibrate at 4°C for at least 3 h. Virions
were treated with extracts (0.4%), 0.5% Triton-X 100 or
DMSO for 1 h at 37°C and loaded onto the top of the gra-
dients. Tubes were centrifuged for 16 h at 40,000 rpm in a
SW60 rotor at 4°C and stopped without a brake. Two
hundred and fifty microliter aliquots were collected
beginning from the top of the tube and stored at -80°C
until analyzed by immunoblotting.
Cell viability studies
Cells were plated and treated with extracts as described
above. Forty h following treatment cell viability was mon-
itored by ATPLite Assay (Packard Biosciences) per manu-
facturer's instructions.
Statistical analysis
Studies were performed at least three independent times
except where noted in the figure legends. Means and
standard errors of the mean are shown. Student's t-test
was used to evaluate the statistical differences between
treatments, utilizing the two-tailed distribution and two-
sample equal-variance conditions. P-values were assessed
by comparing the level of infectivity with treatment to the
level of cytoxicity seen with that same treatment. P-values
for viability were assessed by comparing the level of via-
bility with treatment to the level of viability seen with
DMSO or control. A significant difference was determined
by a p-value of < 0.05 and significance was identified in
each figure. If the p-value was > 0.05, the data were not
considered statistically significantly different.
Results
Aqueous extracts from P. vulgaris inhibit EIAV infectivity 
without significant cell toxicity
Water and ethanol extractions were prepared from four
accessions of Prunella vulgaris. Three of the accessions
(Ames 27664, 27665 and 27666) were collected in west-
ern North Carolina; Ames 27748 was collected in Mis-
souri. Ames 27664 and 27748 were obtained from
disturbed roadside areas whereas the other two accessions
were collected from more remote, forested habitats. These
extracts were screened for their ability to inhibit EIAVWSU5
in a single-round infection assay. Extracts and virus were
diluted in media and immediately incubated with cells.
Forty h following infections, the cells were fixed, immu-
nostained for expression of EIAV antigens and antigen-
positive cells enumerated to determine the level of viral
infection (Fig. 1). Although both ethanol and water
extracts demonstrated some ability to inhibit EIAVWSU5,
water extracts contained the largest quantities of anti-viral
activity. At the concentrations tested, all extracts had little
or no cytotoxicity. Aqueous extracts of Ames 27664 and
27748 had the most significant anti-viral effect against
EIAV. While the aqueous extracts of Ames 27664 and
27748 contained slightly greater concentrations of con-
stituents than the other two aqueous extracts, these mod-
estly higher concentrations could not solely explain the
better activity of these accessions since serial dilutions of
extracts from Ames 27664 and 27748 still had more anti-
viral activity against EIAV than undiluted aqueous extracts
from Ames 27665 and 27666 (Additional file 1). Thus,
aqueous extracts of Ames 27664 and 27748 were further
studied to determine the block in EIAV replication.
To ensure that the effects seen in the initial study were not
viral-strain or cell-type specific, water extracts of P. vulgaris
Ames 27664 and 27748 were tested for inhibition of EIAV
replication in primary cells. Primary equine umbilical
vein endothelial (eUVEC) cells were infected with
EIAVWSU5 in the presence of the extracts and EIAV infec-
tion was inhibited to a similar degree as observed in ED
cells (Fig. 2A). Extracts also showed no cytotoxicity in the
primary cells.
Water extracts of P. vulgaris inhibit lentiviral infectivity with  low cell toxicity Figure 1
Water extracts of P. vulgaris inhibit lentiviral infectiv-
ity with low cell toxicity. DMSO, water extracts and etha-
nol extracts of P. vulgaris were diluted in media to 0.2% 
(water extracts: 66 μg/mL of Ames 27664, 42.2 μg/mL of 
Ames 27665, 59.6 μg/mL of Ames 27666, or 62.4 μg/mL of 
Ames 27748 and ethanol extracts: 66.8 μg/mL of Ames 
27664, 69.2 μg/mL of Ames 27665, 64.2 μg/mL of Ames 
27666, or 67.4 μg/mL of Ames 27748). Equivalent quantities 
of EIAVWSU5 were added to each well of ED cells along with 
the diluted extracts. Forty h following infection, cells were 
fixed and immunostained for viral antigen. Cell-viability stud-
ies were performed in parallel. Cell viability and virus infec-
tivity are shown as a ratio of the values in the presence of the 
extracts divided by the DMSO control. Shown are the aver-
ages and standard errors of three experiments performed in 
triplicate. *, p < 0.05; **, p < 0.001.
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Aqueous extracts of Ames 27664 and 27748 were also
tested for their ability to inhibit a variety of EIAV strains
(Fig. 2B). Two tissue-culture adapted strains, EIAVMA1 and
EIAVSP19, as well as a field isolate, EIAVTh1, and a variant
superinfecting strain, EIAVvMA1c, were effectively inhibited
by the extracts. Previous studies have demonstrated that
EIAVvMA1c enters ED cells through an alternative pathway
compared to its parental strain EIAVMA1  [28-30].
EIAVvMA1c  enters ED cells through plasma membrane
fusion whereas EIAVMA1 and other wild-type strains of
EIAV enter ED cells through interaction with the cellular
receptor ELR1 that is mediated by a low-pH dependent,
clathrin-mediated endocytosis event. The observation that
the P. vulgaris extracts inhibit both the wild-type strains
and variant strain equivalently suggest that Prunella anti-
viral activity is broadly inhibitory and does not block spe-
EIAV inhibition by water extracts of Prunella Ames 27664 and 27748 is not cell type or strain specific Figure 2
EIAV inhibition by water extracts of Prunella Ames 27664 and 27748 is not cell type or strain specific. A) EIAV 
infections of UVECs. DMSO and water extracts of Ames 27664 and 27748 were diluted in media to 0.1% (33 μg/mL of Ames 
27664 or 31.2 μg/mL of Ames 27748) or 0.2% (66 μg/mL of 27664 or 62.4 μg/mL of 27748). EIAVWSU5 virus was added to the 
diluted extracts and immediately used to infect eUVECs. B) Inhibition of infection of four EIAV strains was evaluated in ED cells 
in the presence of 0.2% P. vulgaris aqueous extracts of Ames 27664 and 27748 or DMSO. Forty h following infection, cells were 
immunostained for EIAV antigen. Parallel cultures that were treated with extract, but not infected were evaluated for cell via-
bility. Shown are the ratios of the values in the presence of the extracts divided by the DMSO control. Shown are the averages 
and standard errors of three experiments performed in triplicate. *, p < 0.05; **, p < 0.001.
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Dose dependent inhibition of aqueous extracts of Prunella Ames 27664 and 27748 to inhibit EIAV infection. 
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cific viral-entry events, such as viral glycoprotein/ELR1
interactions.
To examine the inhibition of the Prunella aqueous extracts
more closely, dose response curves were generated and the
concentrations of extracts required to inhibit 50% and
90% of viral infection (IC50 and IC90, respectively) deter-
mined. Fifty percent of EIAVWSU5 infectivity is inhibited
with 27.2 μg/mL of Prunella Ames 27664 and 28.7 μg/mL
of Prunella Ames 27748, and ninety percent is inhibited by
85.9 μg/mL and 76.8 μg/mL, respectively (Fig. 3A and
3B). While the dose of extract needed to inhibit 50% of
cell viability (LD50) could not be determined due to lim-
ited observed cytotoxicity, an approximate 40% reduction
in viability was observed at the highest dose tested (600
μg/mL) suggesting that the therapeutic window (LC50/
IC50) was more than 20-fold.
Prunella extracts primarily inhibit early steps in the EIAV 
life-cycle
To determine step(s) during the viral life cycle that are
inhibited by the extracts, time-of-addition experiments
were performed. In the first set of experiments, ED cells
were infected with EIAVWSU5 and at six time points follow-
ing infection, aqueous extracts were added to the infected
cells. Addition of extracts at 1–4 h following initiation of
infection effectively inhibited virus replication with a
decreasing impact of extract addition over time (Fig. 4A).
We have previously shown that EIAV binds to cells within
six h of infection [30]. Here we demonstrate that by six h,
the addition of the extracts did not have a statistically sig-
nificant effect on EIAV infectivity. This finding indicated
that the inhibition by Prunella extract was occurring prior
to or during virus entry.
Because the aqueous extracts were inhibiting early steps in
the viral life-cycle, we sought to determine if the extracts
interfered with entry steps either prior to or following
virus binding to permissive cells. Virus was pre-bound to
ED cells at 4°C to permit binding, but prevent internaliza-
tion. After the one h binding step, unbound virions were
removed and the cells shifted to 37°C to promote inter-
nalization. Extracts were added at various times following
the temperature shift to 37°C. Under these conditions,
our previous studies have demonstrated that EIAV is inter-
nalized from the surface of ED cells within four h [29].
When EIAV was pre-bound, EIAV infectivity at early times
of infection (1–4 h) was less sensitive to Prunella inhibi-
tion than when virus was not pre-bound (Fig. 4B and
Table 2). For instance in the absence of a pre-binding step,
the addition of Prunella extracts at 2 h resulted in 77%
inhibition of infectivity. In contrast, if the virus was pre-
bound, 53% of the virus was sensitive to Prunella inhibi-
tion. This finding suggested that constituents in Prunella
aqueous extracts were interfering to some extent with
virus binding to ED cells and a pre-binding step decreased
the inhibition observed at early time points. However,
smaller, but significant reduction in viral infectivity was
also observed following a pre-binding step, indicating
Prunella  aqueous extracts interfere with post-binding
events as well.
We also tested the ability of Prunella aqueous extracts to
inhibit virions that have been internalized from the cell
surface. Virions were bound to ED cells at 4°C, unbound
virions were removed, fresh media replaced and the cells
shifted to 37°C to promote virion internalization. At 0, 1,
2, 4, and 6 h following 37°C temperature shift, the cells
were treated with citric acid buffer that inactivates all viri-
ons remaining on the cell surface. The cells were washed
and media containing DMSO or extracts added to the cells
and maintained for the 40 h infection. Internalized viri-
ons were not impacted by Prunella extracts (Fig. 4C). In
total, our data suggest that the Prunella extracts inhibit
EIAV infectivity by interfering with virus binding and sub-
sequent requisite steps that occur prior to virion internal-
ization. However, once the virions are internalized, the
extract was not inhibitory.
Next we wanted to determine if exposing the cells to the
extracts, without exposing the virions, could inhibit EIAV
replication. ED cells were incubated with the extracts for
two h. The medium was changed and cells infected with
EIAVWSU5. Pre-exposure of cells to the extracts from
Prunella Ames 27748 reduced the level of infectivity by
15% which was statitistically significantly different from
the control (Fig. 5A). The modest inhibition observed
with extracts of Ames 27664 was not found to be statisti-
cally significant because of larger amounts of experimen-
tal variation in studies performed with this extract. The
limited antiviral activity found in this experiment is con-
sistent with the time-of-addition studies, suggesting that
Table 2: Percent of virus added that is sensitive to Prunella 
extracts
Time of addition (hr)
Treatment 0 1 2 3 4 6 8
No pre-binding 78 79 77 69 50 31 17
Pre bound virions 72 52 53 32 34 29 18
Internalized virions 0- 17n d5- 3 n d
Percent of virions sensitive to the extracts was calculated by 
subtracting the infectivity in the presence of the extracts from the 
DMSO control at each time point. Data from the extracts 27666 and 
27748 were averaged. nd, data not determined.Virology Journal 2009, 6:8 http://www.virologyj.com/content/6/1/8
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Early steps in the EIAV life cycle are inhibited by Prunella aqueous extracts Figure 4
Early steps in the EIAV life cycle are inhibited by Prunella aqueous extracts. A) Time frame of extract inhibition of 
EIAV infection. ED cells were infected with EIAVWSU5 virus and, at times noted following infection, DMSO, Ames 27664 
extract, or Ames 27748 extract was added to the cells to a final concentration of 0.2% (66 μg/mL of Ames 27664 or 62.4 μg/
mL of Ames 27748). B) Time frame of extract inhibition of EIAVWSU5 that was previously bound to ED cells. Viral particles 
were bound to ED cells at 4°C for 1 h. Unbound virus was removed and cells were shifted to 37°C. At the times indicated, 
DMSO, Ames 27664 extract or Ames 27748 extract was added to the cells to a final concentration of 0.2%. The percent of 
infected cells was determined by dividing the number of EIAV antigen positive cells in the presence of extract compared to the 
number of EIAV antigen positive cells in the presence of DMSO at time zero. C) Time frame of extract inhibition of EIAVWSU5 
following virion internalization. Virions were bound to ED cells at 4°C for 1 h, unbound virions were removed, fresh media was 
replaced, and cells were permitted to internalize at 37°C. At the time points indicated, the cells were washed with citric acid 
buffer to inactivate any non-internalized virions, washed and media containing DMSO, Ames 27664 extract, or Ames 27748 
extract was added (0.2%). Data represent the average and standard error of three experiments performed in duplicate. Prunella 
extracts significantly decreased EIAV infectivity compared to DMSO control at 0, 1, 2, 3, and 4 h time points in panels A and B 
(p < 0.05). Differences observed at 6 and 8 h were not statistically significant.
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the extracts need to come in direct contact with the virions
for the most robust inhibition.
To determine the reduction in particle infectivity by P. vul-
garis  extracts, we incubated 105  infectious virions of
EIAVWSU5 with 25 to 100 μg/mL of extract for 10 min at
room temperature. Virions were serially diluted in media
containing the same concentration of extract and plated
on ED cells. Virus infectivity was evaluated 40 h later.
Incubation of virions with aqueous extract has a profound
impact on virion infectivity with 100 μg/mL of extract
resulting in greater than 3000-fold reduction in infectiv-
ity, indicating that the majority of the anti-viral effect seen
is caused by the extracts interacting with the viral particles
directly, rather than inhibiting later steps in the viral life-
cycle (Fig.5B).
Prunella vulgaris extracts inhibit virion binding to cells
To determine if loss of virion infectivity was the result of
reduced ability of virions to bind to permissive cells in the
presence of Prunella extract, EIAV was incubated in the
presence of the extracts on cells for 2 h at 4°C. These con-
ditions allow binding, but prevent particle internaliza-
tion. Unbound virions were removed and cells and
virions associated with the cells were lysed. Lysates were
examined for the presence of the viral protein, Capsid, to
determine if the extracts reduced EIAV binding to the per-
missive cell population. When incubated with the DMSO
control, EIAV Capsid protein was found in the lysates (Fig.
6). When the virions were exposed to the Prunella extracts,
little or no Capsid was found to be associated with the
lysates, indicating the extracts inhibit this initial step of
viral replication.
Virions treated with Prunella extract are intact
Because the extracts were directly inhibitory to the viral
particle binding to permissive cells, we wanted to deter-
mine if the extracts destroyed the viral particle thereby
rendering them non-infectious and unable to bind to per-
missive cells. Immunoblots of density gradient separated,
extract-treated viral particles were performed to evaluate
the integrity of the virions. Viral Gag proteins were found
in fractions 5, 6, 7 and 8 when the virions were treated
with DMSO (Fig. 7A). Triton X-100 lysis of the virions
resulted in the presence of Capsid protein in the top three
fractions (Fig. 7B). The vast majority of Gag proteins was
also found in fractions 5, 6, and 7 after treated with the
Prunella extracts in a manner similar to that of the DMSO
control (Fig. 7C). However, Gag proteins in Prunella
treated samples were no longer present in fraction 8 and a
modest percentage of these proteins was now found in the
top of the gradient. These findings suggest that in general
extracts did not destroy the virions or dramatically alter
their density.
Fractionation of whole-plant extracts
Aqueous extracts of Prunella would be anticipated to con-
tain abundant amounts of carbohydrates, phenolics and
other water-soluble constituents. To begin to identify
Prunella constituents within the aqueous extracts that are
important for the anti-EIAV activity, the aqueous extract of
Prunella Ames 27748 was separated by a Sephacryl 200
size-exclusion chromatography column into nine frac-
tions. Both the distinct color of each of the fractions as
well as LC/MS analysis of the fractions indicated that suc-
cessful separation of Prunella constituents was achieved
(data not shown). These fractions were resuspended in
endotoxin-free water at a stock concentration of 100 mg/
mL and were tested for anti-EIAV activity. Surprisingly,
Prunella extracts inhibit EIAV infectivity primarily by acting on  viral particles Figure 5
Prunella extracts inhibit EIAV infectivity primarily by 
acting on viral particles. A) Ability of cell-associated 
Prunella extracts to inhibit EIAV infection. Extracts were incu-
bated with ED cells and removed prior to the addition of 
EIAV. EIAV infection was evaluated at 40 h following infec-
tion. B) Ability of Prunella extracts to inhibit EIAV. 2.2 x 105 
EIAVWSU5 particles were incubated with 25, 50 or 100 μg/mL 
extract from Prunella Ames 27664 extract for 10 minutes at 
room temperature. Viral stocks were diluted in media con-
taining the appropriate concentration of extract and plated 
onto ED cells. Forty h following infection the cells were 
fixed, immunostained for EIAV antigen and enumerated. 
Shown are the numbers of infectious virions/ml. Data repre-
sent the average and standard error of three experiments 
performed in duplicate (A) or triplicate (B). Extracts signifi-
cantly reduced EIAV virion infectivity at all concentrations 
tested.
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fractions 3–9 contained potent anti-viral activity and frac-
tion 2 had some inhibitory activity (Fig. 8A). Significant
levels of cytotoxicity were observed with 100 μg/mL of
fraction 7. Cytotoxicity of fraction 7 was in contrast to
what we had observed with similar concentrations of
aqueous extract suggesting that either cytotoxic com-
pounds were being concentrated in this fraction or that
the separation of constituents resulted in greater cytotox-
icity by some metabolites.
To further characterize the anti-viral constituents in the
fractions, ethanol precipitation of the nine fractions was
performed to separate ethanol-soluble and insoluble
compounds. Constituents present in the sub-fractions
were weighed and resuspended in endotoxin-free water at
concentrations that represented the same ratio between
the soluble and insoluble constituents present in the orig-
inal fraction (see Table 1 for concentrations). A single eth-
anol-soluble fraction, Fraction 6, showed significant
inhibition of EIAV (Fig. 8B). Ethanol-insoluble sub-frac-
tions 4 and 9 displayed potent anti-EIAV activity (Fig. 8C).
Interesting, the ethanol precipitation of fractions 2, 3, 5, 7
and 8 resulted in complete loss of anti-EIAV activity in
either sub-fraction.
To determine if the ethanol precipitation destroyed the
anti-viral activity or if multiple constituents that were sep-
arated during sub-fractionation were required for activity,
we performed reconstitution experiments. The soluble
and insoluble sub-fractions were added together at con-
centrations found in the original fractions and tested for
anti-viral activity (Fig. 8D). The anti-viral activity seen in
the original fraction 2 and 3 was lost after sub-fractiona-
tion and was not reconstituted. Reconstitution of frac-
tions 4 and 9 did not enhance the anti-viral activity over
that observed with the ethanol insoluble sub-fraction
alone. Fraction 6 from the ethanol-soluble sub-fraction
displayed anti-viral activity; however, after reconstitution,
anti-viral activity was enhanced. Surprisingly, anti-viral
activity was restored in fractions 5, 7 and 8 after reconsti-
tution, suggesting synergy between constituents is
required for the anti-viral activity of these fractions.
Discussion
This study identified anti-viral activity against the lentivi-
rus EIAV in aqueous extracts of P. vulgaris. The primary
mechanism of inhibition of viral replication targeted viral
entry. The extracts dramatically reduced infectivity when
incubated with the virions alone and interfered with the
ability of virus to bind to permissive cells. However, entry
of EIAV particles that were pre-bound to ED cells prior to
exposure to the extract was also inhibited, suggesting the
anti-viral activity was not limited to inhibition of viral
binding, but also prevented additional external events
Prunella extracts inhibit virion binding to cells Figure 6
Prunella extracts inhibit virion binding to cells. 
EIAVWSU5 virions mixed with the Prunella (132 μg/mL of 
Ames 27664 or 126 μg/mL of Ames 27748) extracts or 
DMSO and added to ED cells at 4°C to promote binding but 
prevent internalization. After a two h binding period, the 
unbound virions were removed, cells were washed and lysed. 
Cell lysates were immunoblotted for EIAV Gag proteins to 
detect bound virions, and tubulin served as a loading control. 
The experiment was repeated three times. A representative 
blot is shown.
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Prunella extracts do not destroy EIAV particles Figure 7
Prunella extracts do not destroy EIAV particles. 
EIAVWSU5 virions were incubated with DMSO, Triton X-100 
(0.5%), or aqueous extracts of Prunella extract (0.4% final 
concentration, 132 μg/mL of Ames 27664 or 126 μg/mL of 
Ames 27748) for 1 h at 37°C. The treated virions were den-
sity banded on a 20–60% sucrose gradient. Eleven fractions 
were collected and immunoblotted for EIAV Gag proteins, 
Capsid (C) and Matrix (M). The experiment was repeated 
three times and a representative blot is shown.
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Fractionation segregates anti-viral constituents Figure 8
Fractionation segregates anti-viral constituents. ED cells were infected with EIAVWSU5 in the presence of the size exclu-
sion fractions (100 μg/mL) (A), ethanol-soluble sub-fractions (B), ethanol-insoluble sub-fractions (C), or a combination of both 
the ethanol soluble and insoluble fractions at concentrations that reconstitute the original fractions (D). Forty h following infec-
tion, cells were fixed and immunostained for viral antigen. Cell viability studies were performed in parallel. Cell viability and 
virus infectivity are shown as a ratio of the values in the presence of the fractions divided by the control. Data represent the 
average and standard error of three experiments performed in triplicate. *, p < 0.05; **, p < 0.001.
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that are required for subsequent internalization and/or
fusion. These extracts were not blocking specific interac-
tions between EIAV and permissive cells such as the inter-
action of the gp90 glycoprotein and the cellular receptor
ELR1 since the extracts effectively blocked infection of
EIAVvMA-1c which can utilize a different cellular receptor
[30].
Our fractionation studies indicated that numerous
Prunella constituents were present in the aqueous extracts
that have inhibitory activity against EIAV. To begin to
identify the individual constituents responsible for the
anti-viral activity, we separated the aqueous extracts by
size-exclusion chromatography and subsequently sepa-
rated those fractions into ethanol-soluble and insoluble
components. Initial fractionation of the extract by size
was not highly informative since 8 of the 9 fractions
retained anti-viral activity. With five of these fractions,
separation of constituents by ethanol precipitation
resulted in loss of all activity; whereas, the ethanol-soluble
material from one fraction had anti-viral activity and eth-
anol-insoluble sub-fractions from two other fractions
were active. The anti-viral activity found in fractions 4 and
9 were ethanol-insoluble suggesting that carbohydrates
may be responsible for the activity. The activity found in
fraction 6 was ethanol-soluble and therefore is likely to be
polyphenolic in nature. Of the five fractions where activity
was lost upon sub-fractionation, activity was reconstituted
when the ethanol-soluble and insoluble sub-fractions
were combined to regenerate fractions 5, 7 and 8. Our
findings demonstrated that synergy between ethanol-sol-
uble and insoluble constituents is necessary for the anti-
viral activity in these fractions. Botanical constituents
responsible for these anti-viral activities remain to be
identified.
The extracts were found to effectively inhibit a range of
EIAV strains from field isolates to a laboratory variant that
can use a different cellular receptor to enter cells. The inhi-
bition was observed in primary cells as well as a cell line.
The breadth of the anti-viral activity of Prunella extracts
was not unexpected since Prunella aqueous extract had
previously been characterized to inhibit both the distantly
related lentivirus HIV-1 and the unrelated DNA virus
HSV-1 [11,12,16,17]. One of these studies identified a 10
kDa sulfated carbohydrate Prunellin from Prunella
extracts that inhibited HIV-1 entry [16,20]. A carbohy-
drate of approximately that same size was responsible for
inhibiting HSV-1 entry into cells [15]. While not defini-
tively demonstrated, it is likely that Prunellin is also
responsible for the anti-HSV-1 activity. Prunellin may be
responsible for anti-EIAV activity found in ethanol-insol-
uble fraction 4 or 9. However, the ability of ethanol-insol-
uble constituents present in two non-contiguous fractions
to robustly inhibit infectivity implicates additional, cur-
rently unidentified carbohydrates in the anti-viral activity
against EIAV.
Extracts from other Lamiaceae species have been shown to
bind to HIV-1 particles interfering with HIV-1 entry into
permissive cells [22]. HIV-1 virions in the presence of
extracts from lemon balm were shown to be denser in a
sucrose gradient than virions in absence of extracts sug-
gesting that extracts either altered the structure of the par-
ticle resulting in enhanced particle density or the
constituents were bound to virions making the particles
denser [22]. In our study, EIAV virions were not destroyed
by treatment with the extracts. Nor did we observe a
change in EIAV virion density as had been reported for
HIV-1/lemon balm extracts [22]. While, it is likely that the
Prunella extract binds to EIAV particles reducing produc-
tive, but non-specific interactions with target cells, this
interaction did not significantly alter virion density. In
addition, lemon balm extracts were not effective against
HIV particles that were pre-bound to cells [22], a finding
distinctly different from our observations that both bind-
ing events and post-binding events were affected by
Prunella extracts.
The aqueous extracts from two of the Prunella accessions
were significantly more inhibitory than extracts from two
other accessions that were evaluated despite the fact that
all four accessions were field grown in Iowa under similar
conditions. The concentrations of the extracts used in this
study could not account for this observation suggesting
that there is extensive genotypic variation of Prunella in
the field. The two extracts that were most effective were
collected in areas of disturbed habitat adjacent to roads
and are likely to have been recently introduced. In con-
trast, the extracts with weaker anti-EIAV activity were
found in undisturbed, forested areas in North Carolina.
Further genetic and metabolomic studies will be required
to understand this potential constituent diversity within
Prunella vulgaris.
Abbreviations
EIAV: equine infectious anemia virus; ED: equine dermis
cells; eUVEC: equine umbilical vein endothelial cells;
HIV-1: human immunodeficiency virus-1; HSV-1: herpes
simplex virus-1; ELR1: equine lentivirus receptor-1;
DMSO: dimethyl sulfoxide.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MAB was responsible for all of the EIAV studies that were
performed. She organized and wrote the manuscript and
generated the figures. MPW was responsible for the over-
sight of growth of the Prunella and participated in the har-Virology Journal 2009, 6:8 http://www.virologyj.com/content/6/1/8
Page 13 of 13
(page number not for citation purposes)
vesting and processing of the plant material. JAM was
responsible for the collection and documentation of the
Prunella  accessions, the planting, maintenance of the
plants, harvesting and processing of the Prunella. PM was
responsible for the oversight of the Prunella fractionation
and ethanol precipitations. CH was responsible for per-
forming all fractionation of the Prunella. LR and BN were
responsible for GC/MS and LC/MS analysis of the frac-
tions and sub-fractions. WM was responsible for oversight
of the project including design and coordination of the
study. She was principally responsible for the editing of
the manuscript.
Additional material
Acknowledgements
This publication was made possible by grant number 9P50AT004155-06 
from the National Center for Complementary and Alternative Medicine 
(NCCAM) and Office of Dietary Supplements (ODS). Its contents are 
solely the responsibility of the authors and do not necessarily represent the 
official views of the NIEHS, NCCAM, or NIH. Mention of commercial 
brand names does not constitute an endorsement of any product by the 
U.S. Department of Agriculture or cooperating agencies.
References
1. Chiej R: Encyclopaedia of Medicinal Plants. MacDonald 1984.
2. Hamada T: [Studies on the medicinal plant in the "Sambutsu-
cho" of Higo Province possessed by the Kumamoto clan (II):
on the medicina herbs].  Yakushigaku Zasshi 1993, 28:63-72.
3. Fang X, Yu MM, Yuen WH, Zee SY, Chang RC: Immune modula-
tory effects of Prunella vulgaris L. on monocytes/macro-
phages.  Int J Mol Med 2005, 16:1109-1116.
4. Fang X, Chang RC, Yuen WH, Zee SY: Immune modulatory
effects of Prunella vulgaris L.  Int J Mol Med 2005, 15:491-496.
5. Ryu SY, Oak MH, Yoon SK, Cho DI, Yoo GS, Kim TS, Kim KM: Anti-
allergic and anti-inflammatory triterpenes from the herb of
Prunella vulgaris.  Planta Med 2000, 66:358-360.
6. Skottova N, Kazdova L, Oliyarnyk O, Vecera R, Sobolova L, Ulrichova
J:  Phenolics-rich extracts from Silybum marianum and
Prunella vulgaris reduce a high-sucrose diet induced oxidative
stress in hereditary hypertriglyceridemic rats.  Pharmacol Res
2004, 50:123-130.
7. Psotova J, Kolar M, Sousek J, Svagera Z, Vicar J, Ulrichova J: Biologi-
cal activities of Prunella vulgaris extract.  Phytother Res 2003,
17:1082-1087.
8. Won J, Hur YG, Hur EM, Park SH, Kang MA, Choi Y, Park C, Lee KH,
Yun Y: Rosmarinic acid inhibits TCR-induced T cell activation
and proliferation in an Lck-dependent manner.  Eur J Immunol
2003, 33:870-879.
9. Ahn SC, Oh WK, Kim BY, Kang DO, Kim MS, Heo GY, Ahn JS: Inhib-
itory effects of rosmarinic acid on Lck SH2 domain binding
to a synthetic phosphopeptide.  Planta Med 2003, 69:642-646.
10. Valentova K, Truong NT, Moncion A, de Waziers I, Ulrichova J:
Induction of glucokinase mRNA by dietary phenolic com-
pounds in rat liver cells in vitro.  J Agric Food Chem 2007,
55:7726-7731.
11. Chiu LC, Zhu W, Ooi VE: A polysaccharide fraction from
medicinal herb Prunella vulgaris downregulates the expres-
sion of herpes simplex virus antigen in Vero cells.  J Ethnophar-
macol 2004, 93:63-68.
12. Kageyama S, Kurokawa M, Shiraki K: Extract of Prunella vulgaris
spikes inhibits HIV replication at reverse transcription in
vitro and can be absorbed from intestine in vivo.  Antivir Chem
Chemother 2000, 11:157-164.
13. Nolkemper S, Reichling J, Stintzing FC, Carle R, Schnitzler P: Antivi-
ral effect of aqueous extracts from species of the Lamiaceae
family against Herpes simplex virus type 1 and type 2 in
vitro.  Planta Med 2006, 72:1378-1382.
14. Xu HX, Lee SH, Lee SF, White RL, Blay J: Isolation and character-
ization of an anti-HSV polysaccharide from Prunella vulgaris.
Antiviral Res 1999, 44:43-54.
15. Zhang Y, But PP, Ooi VE, Xu HX, Delaney GD, Lee SH, Lee SF:
Chemical properties, mode of action, and in vivo anti-herpes
activities of a lignin-carbohydrate complex from Prunella vul-
garis.  Antiviral Res 2007, 75:242-249.
16. Yao XJ, Wainberg MA, Parniak MA: Mechanism of inhibition of
HIV-1 infection in vitro by purified extract of Prunella vul-
garis.  Virology 1992, 187:56-62.
17. Liu S, Jiang S, Wu Z, Lv L, Zhang J, Zhu Z, Wu S: Identification of
inhibitors of the HIV-1 gp41 six-helix bundle formation from
extracts of Chinese medicinal herbs Prunella vulgaris and Rhi-
zoma cibotte.  Life Sci 2002, 71:1779-1791.
18. Au TK, Lam TL, Ng TB, Fong WP, Wan DC: A comparison of HIV-
1 integrase inhibition by aqueous and methanol extracts of
Chinese medicinal herbs.  Life Sci 2001, 68:1687-1694.
19. Lam TL, Lam ML, Au TK, Ip DT, Ng TB, Fong WP, Wan DC: A com-
parison of human immunodeficiency virus type-1 protease
inhibition activities by the aqueous and methanol extracts of
Chinese medicinal herbs.  Life Sci 2000, 67:2889-2896.
20. Tabba HD, Chang RS, Smith KM: Isolation, purification, and par-
tial characterization of prunellin, an anti-HIV component
from aqueous extracts of Prunella vulgaris.  Antiviral Res 1989,
11:263-273.
21. Kim HK, Lee HK, Shin CG, Huh H: HIV integrase inhibitory
activity of Agastache rugosa.  Arch Pharm Res 1999, 22:520-523.
22. Geuenich S, Goffinet C, Venzke S, Nolkemper S, Baumann I, Plinkert
P, Reichling J, Keppler OT: Aqueous extracts from peppermint,
sage and lemon balm leaves display potent anti-HIV-1 activ-
ity by increasing the virion density.  Retrovirology 2008, 5:27.
23. O'Rourke K, Perryman LE, McGuire TC: Antiviral, anti-glycopro-
tein and neutralizing antibodies in foals with equine infec-
tious anaemia virus.  J Gen Virol 1988, 69:667-674.
24. Carpenter S, Chesebro B: Change in host cell tropism associ-
ated with in vitro replication of equine infectious anemia
virus.  J Virol 1989, 63:2492-2496.
25. Maury W, Wright PJ, Bradley S: Characterization of a cytolytic
strain of equine infectious anemia virus.  J Virol 2003,
77:2385-2399.
26. Payne SL, Rausch J, Rushlow K, Montelaro RC, Issel C, Flaherty M,
Perry S, Sellon D, Fuller F: Characterization of infectious molec-
ular clones of equine infectious anaemia virus.  J Gen Virol 1994,
75:425-429.
27. Maury WJ, Carpenter S, Graves K, Chesebro B: Cellular and viral
specificity of equine infectious anemia virus Tat transactiva-
tion.  Virology 1994, 200:632-642.
28. Brindley MA, Maury W: Endocytosis and a low-pH step are
required for productive entry of equine infectious anemia
virus.  J Virol 2005, 79:14482-14488.
29. Brindley MA, Maury W: Equine infectious anemia virus entry
occurs through clathrin-mediated endocytosis.  J Virol 2008,
82:1628-1637.
30. Brindley MA, Zhang B, Montelaro RC, Maury W: An equine infec-
tious anemia virus variant superinfects cells through novel
receptor interactions.  J Virol 2008, 82:1628-37.
31. Weakley AS: Flora of the Carolinas, Virginia, and Georgia, and Surrounding
Areas Chapel Hill, NC: University of North Carolina Herbarium
(NCU), North Carolina Botanical Garden, University of North Caro-
lina at Chapel Hill; 2007. 
Additional file 1
Supplementary figure 1. Water extracts of P. vulgaris inhibit lentiviral 
infectivity with low cell toxicity.
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